跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Ertugliflozin Tablets
Approved
化学药品
Ertugliflozin Tablets
Merck Sharp & Dohme BV
🇨🇳 National Medical Products Administration
Approval Date
Jan 26, 2025
Approval ID
81u8kAgwNQB
Company
Merck Sharp & Dohme BV
Type
化学药品
Approval Details
Approval Id
81u8kAgwNQB
Approval Number
国药准字HJ20200023
Generic Name
艾托格列净片
Generic Name En
Ertugliflozin Tablets
Trade Name
捷诺妥
Brand Name
捷诺妥
Drug Type
化学药品
Dosage Form
片剂
Strength
5mg(以艾托格列净计)
Reg Date
2025-01-26
Expired Date
2030-01-25
Company Name
Merck Sharp & Dohme BV
Production Company Name
Pfizer Manufacturing Deutschland GmbH
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Production Company Detail Path
/organization/pfizer-manufacturing-deutschland-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 26, 2025
Approval ID
81u8kAgwNQB
Type
化学药品
Back to NMPA Approvals
捷诺妥 - NMPA Drug Approval Details